Evidence map›Paper›PMID 34998413›Full record

ArticleBMC health services research2022

Enhancing and promoting data management and systematic monitoring for an improved HIV/AIDS programs in Addis Ababa, Ethiopia.

Dereje Habte, Samuel Zemenfeskudus, Mulugeta Endale, Mohammed Zeidan, Daniel Getachew, Dejene Woldemichael, Aklilu S Wesene, Esayas Teklebirhan, Fitsum Eyayu, Raey Zewdie and 4 more

Abstract read
In one paragraph

Article in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Dereje HabteThe United States Centers for Disease Control and Prevention, Division of Global HIV & TB, Addis Ababa, Ethiopia. oii7@cdc.gov.
Samuel ZemenfeskudusAddis Ababa City Administration Health Bureau, Addis Ababa, Ethiopia.
Mulugeta EndaleAddis Ababa City Administration Health Bureau, Addis Ababa, Ethiopia.
Mohammed ZeidanThe United States Centers for Disease Control and Prevention, Division of Global HIV & TB, Addis Ababa, Ethiopia.
Daniel GetachewAddis Ababa City Administration Health Bureau, Addis Ababa, Ethiopia.
Dejene WoldemichaelAddis Ababa City Administration Health Bureau, Addis Ababa, Ethiopia.
Aklilu S WeseneAddis Ababa City Administration Health Bureau, Addis Ababa, Ethiopia.
Esayas TeklebirhanICAP at Columbia University, Addis Ababa, Ethiopia.
Fitsum EyayuICAP at Columbia University, Addis Ababa, Ethiopia.
Raey ZewdieICAP at Columbia University, Addis Ababa, Ethiopia.
Daniel YirgaAddis Ababa City Administration Health Bureau, Addis Ababa, Ethiopia.
Worknesh AmdinoICAP at Columbia University, Addis Ababa, Ethiopia.
Zenebe MelakuICAP at Columbia University, Addis Ababa, Ethiopia.
Sisay A AbaynehThe United States Centers for Disease Control and Prevention, Division of Global HIV & TB, Addis Ababa, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEthiopia Population-based HIV Impact Assessment findings showed that in Addis Ababa, only 65.2% of people living with HIV (PLHIV) know their status. We present the enhanced HIV/AIDS data management and systematic monitoring experience in Addis Ababa City Administration Health Bureau (AACAHB).

methodsAACAHB established a command-post with leadership and technical team members from the health bureau, 10 sub-city health offices, and non-governmental stakeholders. The command-post improved governance, standardized HIV program implementation, and established accountability mechanism. A web-based database was established at each health facility, sub-city, and AACAHB level. Performance was scored (green, ≥75%; yellow, 50-74%; red, < 50%). The command-post reviewed performance on weekly basis. A mentorship team provided a weekly site-level support at underperforming public and private health facilities. At facility level, quality of data on recording tools such as registers, and individual medical records were maintained through continued review, feedback mechanisms and regular consistency check of data. Percentage and 95% confidence interval were computed to compare the improvement in program performance over time.

resultsAfter 6 months of intervention period, the monthly New HIV case finding in 47 health facilities increased from 422 to 734 (1.7 times) and treatment initiation increased from 302 to 616 (2 times). After 6 months, the aggregate scoring for HIV testing at city level improved from yellow to green, HIV case finding improved from red to green, and treatment initiation improved from red to yellow. An increasing trend was noted in HIV positive case finding with statistically significant improvement from 43.4% [95% Confidence Interval: 40.23-46.59%] in May 2019 to 74.9% [95% Confidence Interval: 72.03-77.6%] in September 2019. Similarly, significant improvement was recorded for new HIV treatment from 30.9% [95% Confidence Interval: 28.01-33.94%] in May 2019 to 62.5% [95% Confidence Interval: 59.38-65.6%] in September 2019.

conclusionsRegular data driven HIV program review was institutionalized at city, sub-city and health facility levels which further improved HIV program monitoring and performance. The performance of HIV case finding and treatment initiation improved significantly via using intensified monitoring, data driven performance review, targeted site-level support based on the gap, and standardized approaches.

Indexed as

Acquired Immunodeficiency SyndromeHIV InfectionsData ManagementEthiopiaHealth FacilitiesHumansPrivate FacilitiesAddis AbabaAnti-retroviral treatmentData useHIV programHIV testingHuman immunodeficiency virus (HIV)Information useMonitoring and evaluation

Identifiers

PMID34998413
PMCPMC8742942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.